Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke - PubMed (original) (raw)
Review
doi: 10.5551/jat.e529. Epub 2007 Dec 17.
Affiliations
- PMID: 18174657
- DOI: 10.5551/jat.e529
Free article
Review
Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke
Hirotsugu Ueshima. J Atheroscler Thromb. 2007 Dec.
Free article
Abstract
Japan's age-adjusted rate for mortality from stroke increased after the Second World War until 1965 and then showed a significant decline until 1990; however, the age-adjusted rate for mortality from all heart disease and coronary heart disease (CHD) increased until 1970 and then declined slowly. A puzzling question is why the rate of mortality from CHD declined in spite of an increase in serum total cholesterol level following an increase in fat consumption. It was confirmed that CHD incidence was far lower in several Japanese populations compared to Western countries in the " Monitoring Trends and Determinants in Cardiovascular Disease " (MONICA) project; therefore, the lower CHD mortality in Japan stems from the lower CHD incidence. CHD risk factors based on epidemiologic cohort studies in Japan were no different from those of other industrialized countries: hypertension, hypercholesterolemia, smoking and diabetes mellitus (DM). So, how can we explain this phenomenon?There are three possible explanations. One is the decline in population blood pressure level and the prevalence of hypertension during the years 1965-1990; the second is the decline in smoking rate in men and women; the third is that the serum total cholesterol level for middle-aged and elderly populations remains 5-15 mg/dL lower than that of the US elderly counterpart, although men aged 40-49 in Japan and the US had similar serum total cholesterol levels. It was also noted that elderly people in Japan, as observed in the Seven Countries Study, had far lower serum total cholesterol levels in midlife, i.e., around 160 mg/dL in the 1960s. This was not the case for elderly in the US where a higher serum total cholesterol level was observed in midlife. In conclusion, the lower serum cholesterol level in the past of Japanese middle-aged and elderly people compared to Western counterparts helps to maintain the low CHD incidence and mortality supported by the declining trend in blood pressure level and smoking rate for both men and women.
Similar articles
- Lifestyle and cardiovascular disease in Japan.
Iso H. Iso H. J Atheroscler Thromb. 2011;18(2):83-8. doi: 10.5551/jat.6866. Epub 2011 Feb 5. J Atheroscler Thromb. 2011. PMID: 21307610 Review. - Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study.
Sekikawa A, Miyamoto Y, Miura K, Nishimura K, Willcox BJ, Masaki KH, Rodriguez B, Tracy RP, Okamura T, Kuller LH. Sekikawa A, et al. Int J Epidemiol. 2015 Oct;44(5):1614-24. doi: 10.1093/ije/dyv143. Epub 2015 Jul 16. Int J Epidemiol. 2015. PMID: 26182938 Free PMC article. - Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).
Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group. Sone H, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):3448-56. doi: 10.1210/jc.2011-0622. Epub 2011 Aug 24. J Clin Endocrinol Metab. 2011. PMID: 21865372 - Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies.
Nakamura K, Nakagawa H, Sakurai M, Murakami Y, Irie F, Fujiyoshi A, Okamura T, Miura K, Ueshima H; EPOCH-JAPAN Research Group. Nakamura K, et al. Cerebrovasc Dis. 2012;33(5):480-91. doi: 10.1159/000336764. Epub 2012 Apr 19. Cerebrovasc Dis. 2012. PMID: 22517421 - Prognostic interactions between cardiovascular risk factors.
Vishram JK. Vishram JK. Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
Cited by
- Lifestyle Medicine and Japan's Longevity Miracle.
Shirai T, Tsushita K. Shirai T, et al. Am J Lifestyle Med. 2024 Mar 19;18(4):598-607. doi: 10.1177/15598276241234012. eCollection 2024 Jul-Aug. Am J Lifestyle Med. 2024. PMID: 39262888 Free PMC article. - Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review.
Higashiyama A, Kohsaka S, Fujiyoshi A. Higashiyama A, et al. J Atheroscler Thromb. 2024 Aug 1;31(8):1113-1128. doi: 10.5551/jat.RV22019. Epub 2024 Jun 1. J Atheroscler Thromb. 2024. PMID: 38825504 Free PMC article. Review. - Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention.
Hisamatsu T, Kinuta M. Hisamatsu T, et al. J Atheroscler Thromb. 2023 Oct 1;30(10):1289-1302. doi: 10.5551/jat.RV22009. Epub 2023 Jul 1. J Atheroscler Thromb. 2023. PMID: 37394660 Free PMC article. Review. - Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection.
Haruhara K, Kanzaki G, Tsuboi N. Haruhara K, et al. Hypertens Res. 2023 Feb;46(2):299-310. doi: 10.1038/s41440-022-01061-5. Epub 2022 Oct 12. Hypertens Res. 2023. PMID: 36224286 Free PMC article. Review. - The association between the socioeconomic deprivation level and ischemic heart disease mortality in Japan: an analysis using municipality-specific data.
Okui T, Matoba T, Nakashima N. Okui T, et al. Epidemiol Health. 2022;44:e2022059. doi: 10.4178/epih.e2022059. Epub 2022 Jul 14. Epidemiol Health. 2022. PMID: 35879856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous